Krishna Vaddi is CEO at Prelude Therapeutics Inc (PRLD). They have made 10 open-market trades across 1 company since 2022, most recently 2025-03-25.
CIK 0001824633
10 open-market purchases totalling $1.5M since 2022, never a sale. Across 10 scored buys the stock is down 9.1% at ninety days, and 11.3 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PRLD | 1,999,296 | $6.5M |
Shares reported on the most recent Form 4, priced at the 2025-03-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 50% |
| Avg Move | -7.0% | +0.1% | -9.1% |
| Alpha | -5.5% | +0.8% | -11.3% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | BUY | 2025-03-25 | 2025-03-27 | $0.69 | $932K | -24.1% | +10.2% | +6.3% |
| PRLD | BUY | 2025-03-20 | 2025-03-24 | $0.73 | $15K | -6.8% | +16.2% | +10.5% |
| PRLD | BUY | 2025-03-14 | 2025-03-18 | $0.75 | $29K | +12.6% | +14.1% | +37.2% |
| PRLD | BUY | 2025-03-12 | 2025-03-14 | $0.72 | $70K | -14.7% | -7.5% | +38.7% |
| PRLD | BUY | 2024-12-31 | 2025-01-03 | $1.21 | $6K | -26.1% | -19.6% | -48.7% |
| PRLD | BUY | 2024-12-30 | 2025-01-02 | $1.20 | $12K | -26.4% | -20.7% | -43.8% |
| PRLD | BUY | 2024-12-18 | 2024-12-20 | $0.93 | $99K | +6.5% | -6.5% | -43.6% |
| PRLD | BUY | 2023-05-24 | 2023-05-26 | $5.15 | $10K | -1.5% | -20.8% | -36.3% |
| PRLD | BUY | 2023-05-23 | 2023-05-25 | $5.63 | $133K | +9.2% | -14.9% | -34.2% |
| PRLD | BUY | 2022-12-20 | 2022-12-21 | $5.13 | $197K | +1.9% | +50.3% | +23.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.